
Buoy Health is a digital health company that uses AI technology combined with clinical expertise to help people understand their symptoms and find the right care. Founded by Andrew Le, M.D., the company aims to simplify the US healthcare system by providing a symptom checker that asks personalized questions to guide users to appropriate care options. Buoy's platform includes medically reviewed content and curated recommendations for products, services, and doctors, ensuring clarity and actionable health information. The company operates with a mission to reduce healthcare complexity and improve patient outcomes, positioning itself as a trusted digital health navigation tool with a strong clinical foundation and growing market presence.

Buoy Health is a digital health company that uses AI technology combined with clinical expertise to help people understand their symptoms and find the right care. Founded by Andrew Le, M.D., the company aims to simplify the US healthcare system by providing a symptom checker that asks personalized questions to guide users to appropriate care options. Buoy's platform includes medically reviewed content and curated recommendations for products, services, and doctors, ensuring clarity and actionable health information. The company operates with a mission to reduce healthcare complexity and improve patient outcomes, positioning itself as a trusted digital health navigation tool with a strong clinical foundation and growing market presence.
Founded: 2014
Headquarters: Boston, Massachusetts, United States
Product: AI-powered symptom checker and care-triage
CEO: Andrew Le, M.D.
Total funding: 63220000.00 USD
Employees: 31
Symptom checking and care navigation/triage
2014
Health technology
6.7M USD
Included FundRx and various angel investors.
Investors listed for the round include Optum Ventures, MBX Capital, Humana, F-Prime, Cigna Ventures, and William Hambrecht.
Participating investors included Optum Ventures, WR Hambrecht + Co, and Trustbridge Partners.
“Series C led by Cigna Ventures and Humana; earlier rounds included lead investor F-Prime Capital Partners and participation from Optum Ventures, WR Hambrecht + Co, Trustbridge Partners and angel investors.”